The goal of Accelerate.EU is to establish a stable and reliable cross-European supply chain for 211 At, ensuring broader availability and access to this promising treatment. The project also aims to develop a cutting-edge cyclotron and to enable the deployment of a distribution network to produce 211At for hospitals.
As the project progresses, Accelerate.EU will continue to produce comprehensive educational and training content to support the deployment of these innovative solutions, ensuring long-term knowledge dissemination and impact across Europe.
Acceletate.EU is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No [101173001]. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ihi-accelerate.eu
Accelerate.eu Questions
Accelerate.Eu's website is https://ihi-accelerate.eu
Accelerate.Eu's LinkedIn profile is https://www.linkedin.com/company/accelerateeurope
Accelerate.Eu's industry is
Biotechnology Research
Accelerate.Eu's categories are Biotechnology Research
Accelerate.Eu's founding year is 2024
